Andrew P. Hider - 27 Feb 2026 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Reporting relationship: President and CEO, Director
Issuer ticker: BAX
Reported as of: 27 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 19:10:53 UTC
Prior SEC filing: 04 Sep 2025
Next SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Ellen K. Bradford, as attorney in-fact for Andrew P. Hider

Key filing fact

Andrew P. Hider filed Form 4 for BAXTER INTERNATIONAL INC (BAX) on 03 Mar 2026.

Key facts

This page summarizes Andrew P. Hider's Form 4 filing for BAXTER INTERNATIONAL INC (BAX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 19:10.

Change

Previous filing in this sequence was filed on 04 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001940945 Primary reporting owner

Hider Andrew P.

Relationship: President and CEO, Director
Address: ONE BAXTER PARKWAY, DEERFIELD
Signature: /s/ Ellen K. Bradford, as attorney in-fact for Andrew P. Hider
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BAX transaction

Common Stock, $1 par value

Award

Transaction value: $0
Shares: +201,804
Change %: +54%
Price: $0.000000
Shares after: 572,239
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +488,506
Change %
Price: $0.000000
Shares after: 488,506
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock, $1 par value
Underlying amount: 488,506
Exercise price: $20.37
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

Footnote F2

Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

Footnote F3

The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.